Related Experiment Video
Updated: Jun 26, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
COPD as a disease of accelerated lung aging
Kazuhiro Ito1, Peter J Barnes1
1Airways Disease Section, National Heart and Lung Institute, Imperial College London, UK.
Chest
|January 13, 2009
Summary
Accelerated lung aging due to oxidative stress contributes to chronic obstructive pulmonary disease (COPD) and emphysema. Targeting anti-aging molecules offers a potential new therapeutic strategy for COPD.
Area of Science:
- Gerontology
- Pulmonology
- Molecular Biology
Background:
- Aging is linked to chronic inflammatory diseases like COPD.
- COPD, a slow-progressing lung disease, predominantly affects the elderly.
- Oxidative stress accelerates lung aging, contributing to COPD pathogenesis, especially emphysema.
Purpose of the Study:
- To review evidence linking accelerated lung aging to COPD progression.
- To explore the role of oxidative stress and inflammation in COPD pathogenesis.
- To identify potential anti-aging therapeutic targets for COPD.
Main Methods:
- Review of existing scientific literature on aging, oxidative stress, and COPD.
- Analysis of cellular and molecular mechanisms involved in lung aging.
- Examination of signal transduction pathways, including protein acetylation.
Main Results:
- Aging involves DNA damage repair failure and telomere shortening.
- Pulmonary function declines with age, increasing inflammation and structural changes (senile emphysema).
- Environmental factors like pollutants accelerate lung aging by impairing inflammation resolution and reducing anti-aging molecules (e.g., sirtuins).
Conclusions:
- Accelerated lung aging, driven by oxidative stress and inflammation, is implicated in COPD and emphysema.
- Reduced levels of anti-aging molecules like histone deacetylases and sirtuins worsen COPD progression.
- Novel anti-aging molecules identified through signal transduction research may offer new COPD therapeutic avenues.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...